Hemogenyx Pharmaceuticals Plc Stock Price on December 10, 2024
| HOPHF Stock | USD 1.24 0.00 0.00% |
If you're considering investing in Hemogenyx Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Hemogenyx Pharmaceuticals stands at 1.24, as last reported on the 9th of January, with the highest price reaching 1.24 and the lowest price hitting 1.24 during the day. Hemogenyx Pharmaceuticals is out of control given 3 months investment horizon. Hemogenyx Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We have analyze and collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 14.52% are justified by taking the suggested risk. Use Hemogenyx Pharmaceuticals Plc Risk Adjusted Performance of 0.1088, standard deviation of 4911.55, and Market Risk Adjusted Performance of (3.54) to evaluate company specific risk that cannot be diversified away.
Hemogenyx Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Hemogenyx |
Sharpe Ratio = 0.1136
| Best Portfolio | Best Equity | HOPHF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 127.84 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Hemogenyx Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemogenyx Pharmaceuticals by adding it to a well-diversified portfolio.
Related Headline
Fennec Pharmaceuticals Headline on 10th of December 2024
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec... by Hackman Jeffrey S.
Filed transaction by Fennec Pharmaceuticals Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Hemogenyx Pharmaceuticals Valuation on December 10, 2024
It is possible to determine the worth of Hemogenyx Pharmaceuticals on a given historical date. On December 10, 2024 Hemogenyx was worth 1.24 at the beginning of the trading date compared to the closed value of 1.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Hemogenyx Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Hemogenyx Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hemogenyx Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Hemogenyx Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.24 | 1.24 | 1.24 | 1.24 | 1.00 | |
12/10/2024 | 1.24 | 1.24 | 1.24 | 1.24 | 1.00 |
| 1.24 | 1.24 | 1.24 | 1.24 | 1.00 |
| Backtest Hemogenyx Pharmaceuticals | | | Hemogenyx Pharmaceuticals History | | | Hemogenyx Pharmaceuticals Valuation | Previous | Next |
Hemogenyx Pharmaceuticals Trading Date Momentum on December 10, 2024
| On December 11 2024 Hemogenyx Pharmaceuticals Plc was traded for 1.24 at the closing time. The highest daily price throughout the period was 1.24 and the lowest price was 1.24 . There was no trading activity during the period 1.0. Lack of trading volume on 12/11/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Hemogenyx Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Hemogenyx Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Hemogenyx Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Hemogenyx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Hemogenyx Pharmaceuticals Pink Sheet history
Hemogenyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hemogenyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hemogenyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hemogenyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. Hemogenyx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Hemogenyx Pharmaceuticals Pink Sheet Technical Analysis
Hemogenyx Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Hemogenyx Pharmaceuticals Period Price Range
Low | January 9, 2025
| High |
0.00 | 0.00 |
Hemogenyx Pharmaceuticals Plc cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Hemogenyx Pharmaceuticals January 9, 2025 Market Strength
Market strength indicators help investors to evaluate how Hemogenyx Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemogenyx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hemogenyx Pharmaceuticals pink sheet market strength indicators, traders can identify Hemogenyx Pharmaceuticals Plc entry and exit signals to maximize returns
Hemogenyx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Hemogenyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Hemogenyx Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hemogenyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1088 | |||
| Jensen Alpha | 602.93 | |||
| Total Risk Alpha | 606.4 | |||
| Treynor Ratio | (3.55) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |